HomeIntelligenceBrief
VULNERABILITY BRIEF🟠 High Vulnerability

Critical Arbitrary Code Execution Vulnerabilities Disclosed in Multiple Ivanti Products (CVE‑2026‑12744, CVE‑2026‑12645, etc.)

Ivanti announced several high‑severity CVEs that could allow unauthenticated attackers to execute code on Endpoint Manager Mobile, Neurons for ITSM, and Sentry gateways. Organizations must patch quickly and capture remediation evidence to satisfy vulnerability‑management controls and audit readiness.

LiveThreat™ Intelligence · 📅 September 10, 2026· 📰 cisecurity.org
🟠
Severity
High
VU
Type
Vulnerability
🎯
Confidence
High
🏢
Affected
2 sector(s)
Actions
3 recommended
📰
Source
cisecurity.org

Multiple Ivanti Products Contain Critical Arbitrary Code Execution Vulnerabilities (CVE‑2026‑12744, CVE‑2026‑12645, etc.)

What Happened — Ivanti disclosed a set of vulnerabilities across its Endpoint Manager Mobile, Neurons for ITSM (cloud and on‑prem), and Sentry gateway products. The most severe flaws are deserialization bugs and a missing‑authorization issue that could let an unauthenticated or low‑privilege attacker execute arbitrary code on the affected server. No public exploitation has been reported to date.

Why It Matters for Trust & Control Assurance

  • The scenario directly tests an organization’s vulnerability‑management control – the ability to discover, assess, and remediate critical flaws before an attacker can leverage them.
  • Continuous evidence of patching and configuration compliance provides a defensible audit trail that maps to many frameworks (e.g., NIST CSF 2.0).
  • Verisq’s Control Mapping capability can automatically correlate these CVEs to the relevant control objectives and surface gaps in your evidence repository.

Who Is Affected

  • Large and medium enterprises using Ivanti’s endpoint‑management or ITSM suites (high risk).
  • Small businesses and government agencies with lower‑tier deployments (medium risk).

Recommended Actions

  • Inventory all Ivanti instances and verify version numbers against the advisory list.
  • Prioritize patching for the listed CVEs; apply vendor‑released updates or mitigations immediately.
  • Record the remediation steps in your control‑evidence platform to demonstrate timely vulnerability response.
  • Review privileged‑account assignments on affected systems; enforce least‑privilege where possible.

Source: CIS Advisory 2026‑093

Technical Notes

  • Attack vector: Exploitation of deserialization of untrusted data and missing authorization checks (remote code execution).
  • CVEs: CVE‑2026‑12744, CVE‑2026‑12745, CVE‑2026‑12648, CVE‑2026‑12649, CVE‑2026‑12650, CVE‑2026‑12651, CVE‑2026‑12645, CVE‑2026‑12646.
  • Potential impact: Installation of malicious programs, data alteration or deletion, depending on the compromised account’s privileges.

Source: CIS Advisory 2026‑093

📰 Original Source
https://www.cisecurity.org/advisory/multiple-vulnerabilities-in-ivanti-products-could-allow-for-arbitrary-code-execution_2026-093

This LiveThreat Intelligence Brief is an independent analysis. Read the original reporting at the link above.

From the Verisq platform · Trust Operations

Misconfigurations are control gaps in disguise.

Verisq AI Trust Operations turns findings like this into mapped controls with continuous evidence, keeping your audit readiness current instead of point-in-time.

Map your controls with Verisq AI Trust Operations →